Adherex Technologies Inc.

FENC Healthcare Biotechnology

Adherex Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.6 million, down 6.09% from fiscal 2024. In the quarter to June 2026, revenue grew 85.2%, EPS grew 154.6% and free cash flow grew 101.4%, each against the same quarter a year earlier.

9.98 0.37 −3.57%
Market cap
$362.9M
P/E
0.0×
Fwd P/E
31.4×
Dividend yield
—
F-score
1/9
Altman Z
0.51
Beneish M
−1.29
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

1 1 6 6
ROE
143.64% (65.82%) (52.68%) (18.58%)
ROA
(12.83%) (16.87%) (14.17%) (5.39%)
ROIC
0.00% 0.00% 0.00% (58.89%)
Return on Tangible Assets
(19.15%) (17.23%) (14.62%) (5.41%)
Average Days of Receivables
182.01 189.86 134.28 143.40
Free Cash Flow per Share
(0.29) (0.44) (0.17) (0.06)
Free Cash Flow
(7.98) (12.47) (5.78) (2.04)
Other line items

Show all line items

Columns are period end dates